Home / Research and experimental development on biotechnology (except medical and veterinary science)

APEX BIOPHARM PTE. LTD.

Live CompanyUEN 202552766NLocal Company

APEX BIOPHARM PTE. LTD. is a local company in Singapore with UEN 202552766N. It was registered on 27 Nov 2025. Its status is Live Company. Its main activity is research and experimental development on biotechnology (except medical and veterinary science).

UEN202552766N
StatusLive Company
Entity typeLocal Company, Exempt Private Company Limited by Shares
Registered27 Nov 2025
Main activity (SSIC)72101 Research and experimental development on biotechnology (except medical and veterinary science)
Secondary activity74909 Other professional, scientific and technical activities n.e.c.
Address138 ROBINSON ROAD, #02-54, OXLEY TOWER, Singapore 068906
2186 companies at this address
AreaDowntown Core · District 1 (Raffles Place, Cecil, Marina, People's Park)
Nearest stationShenton Way MRT, about 185 m
Officers3

Newer companies in research and experimental development on biotechnology (except medical and veterinary science)

  • DAYOU BIOTECHNOLOGY PTE. LTD.202637714W · 18 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PROBIO TECHNOLOGY PRIVATE LIMITED202636974G · 13 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • NEUTHERA PTE. LTD.202636842M · 12 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PC BIOME INNOVATIONS PTE. LTD.202636514M · 11 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • THERALIFE53529115M · 1 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • BIO-SUPPLY INNOVATIONS PTE. LTD.202633668E · 24 Jul 2026 · Research and experimental development on biotechnology (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.